The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2023
Filed:
Aug. 10, 2021
Applicant:
Centrexion Therapeutics Corporation, Boston, MA (US);
Inventors:
Doris Riether, Biberach an der Riss, DE;
Florian Paul Christian Binder, Maselheim, DE;
Henri Doods, Warthausen, DE;
Stephan Georg Mueller, Warthausen, DE;
Janet Rachel Nicholson, Oberhoefen, DE;
Achim Sauer, Ravensburg-Torkenweiler, DE;
Assignee:
Centrexion Therapeutics Corporation, Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 413/12 (2006.01); C07D 261/14 (2006.01); C07D 413/14 (2006.01); C07D 413/02 (2006.01); C07D 261/04 (2006.01); A61K 31/422 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); A61K 31/422 (2013.01); C07D 261/04 (2013.01); C07D 261/14 (2013.01); C07D 413/02 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01);
Abstract
This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.